The Genito Urinary System and Sex Hormones sector in Denmark experienced a decline with 2024 forecasts projecting total sales at 2.8. This decline follows annual reductions: 2.8 in 2024, 2.7 in 2025, 2.6 in 2026, 2.5 in 2027, and 2.4 in 2028. The CAGR shows a -3.73% average drop per year over five years.
Future trends to watch for:
- Technological advancements in drug delivery systems and personalized medicine
- Entry of new competitors focused on innovative treatments
- Potential regulatory changes impacting market dynamics
- Increased focus on preventive healthcare and awareness campaigns
